Pdcd4 deficiency enhances macrophage lipoautophagy and attenuates foam cell formation and atherosclerosis in mice

Cell Death and Disease

Volumn 7, Issue , 2016, Pages e2055-

  Wang, L ^a   Jiang, Y ^a,b   Song, X ^a,c   Guo, C ^a   Zhu, F ^a   Wang, X ^a   Wang, Q ^a   Shi, Y ^a   Wang, J ^a   Gao, F ^d   Zhao, W ^a   Chen, Y H ^e   Zhang, L ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

^c SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

^d SHANDONG UNIVERSITY   (China)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; LIPID; MEMBRANE RECEPTOR; OXIDIZED LOW DENSITY LIPOPROTEIN; PROGRAMMED DEATH 4 RECEPTOR; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; PDCD4 PROTEIN, MOUSE; RNA BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; AUTOPHAGY; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOAM CELL; HEMATOPOIETIC CELL; LIPID DIET; LIPID STORAGE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; UPREGULATION; ANIMAL; DEFICIENCY; GENETICS; METABOLISM;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; ATHEROSCLEROSIS; AUTOPHAGY; FOAM CELLS; MACROPHAGES; MICE; RNA-BINDING PROTEINS;

EID: 84955100816     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2015.416     Document Type: Article

References (41)

1. Weber C, Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nat Med 2011; 17: 1410-1422.
2. Moore KJ, Sheedy FJ, Fisher EA. Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol 2013; 13: 709-721.
3. Ley K, Miller YI, Hedrick CC. Monocyte and macrophage dynamics during atherogenesis. Arterioscler Thromb Vasc Biol 2011; 31: 1506-1516.
4. Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell 2011; 145: 341-355.
5. Ouimet M, Marcel YL. Regulation of lipid droplet cholesterol efflux from macrophage foam cells. Arterioscler Thromb Vasc Biol 2012; 32: 575-581.
6. Tabas I, García-Cardeña G, Owens GK. Recent insights into the cellular biology of atherosclerosis. J Cell Biol 2015; 209: 13-22.
7. Webb NR, Moore KJ. Macrophage-derived foam cells in atherosclerosis: lessons from murine models and implications for therapy. Curr Drug Targets 2007; 8: 1249-1263.
8. Mizushima N. Autophagy: process and function. Genes Dev 2007; 21: 2861-2873.
9. Galluzzi L, Pietrocola F, Levine B, Kroemer G. Metabolic control of autophagy. Cell 2014; 159: 1263-1276.
10. Singh R, Kaushik S, Wang Y, Xiang Y, Novak I, Komatsu M et al. Autophagy regulates lipid metabolism. Nature 2009; 458: 1131-1135.
11. De Meyer GR, Grootaert MO, Michiels CF, Kurdi A, Schrijvers DM, Martinet W. Autophagy in vascular disease. Circ Res 2015; 116: 468-479.
12. Liao X, Sluimer JC, Wang Y, Subramanian M, Brown K, Pattison JS et al. Macrophage autophagy plays a protective role in advanced atherosclerosis. Cell Metab 2012; 15: 545-553.
13. Razani B, Feng C, Coleman T, Emanuel R, Wen H, Hwang S et al. Autophagy links inflammasomes to atherosclerotic progression. Cell Metab 2012; 15: 534-544.
14. Ouimet M, Franklin V, Mak E, Liao X, Tabas I, Marcel YL. Autophagy regulates cholesterol efflux from macrophage foam cells via lysosomal acid lipase. Cell Metab 2011; 13: 655-667.
15. Martinet W, Verheye S, De Meyer GR. Everolimus-induced mTOR inhibition selectively depletes macrophages in atherosclerotic plaques by autophagy. Autophagy 2007; 3: 241-244.
16. Schrijvers DM, De Meyer GR, Martinet W. Autophagy in atherosclerosis: a potential drug target for plaque stabilization. Arterioscler Thromb Vasc Biol 2011; 31: 2787-2791.
17. Shibahara K, Asano M, Ishida Y, Aoki T, Koike T, Honjo T. Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death. Gene 1995; 16: 297-301.
18. Waters LC, Veverka V, Böhm M, Schmedt T, Choong PT, Muskett FW et al. Structure of the C-terminal MA-3 domain of the tumour suppressor protein Pdcd4 and characterization of its interaction with eIF4A. Oncogene 2007; 26: 4941-4950.
19. Lankat-Buttgereit B, Göke R. The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation. Biol Cell 2009; 101: 309-317.
20. Chen Y, Knösel T, Kristiansen G, Pietas A, Garber ME, Matsuhashi S et al. Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis. J Pathol 2003; 200: 640-646.
21. Zhang S, Li J, Jiang Y, Xu Y, Qin C. Programmed cell death 4 (PDCD4) suppresses metastastic potential of human hepatocellular carcinoma cells. J Exp Clin Cancer Res 2009; 28: 71.
22. Yang HS, Matthews CP, Clair T, Wang Q, Baker AR, Li CC et al. Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion. Mol Cell Biol 2006; 26: 1297-1306.
23. Wei ZT, Zhang X, Wang XY, Gao F, Zhou CJ, Zhu FL et al. PDCD4 inhibits the malignant phenotype of ovarian cancer cells. Cancer Sci 2009; 100: 1408-1413.
24. Gao F, Wang X, Zhu F, Wang Q, Zhang X, Guo C et al. PDCD4 gene silencing in gliomas is associated with 5′CpG island methylation and unfavourable prognosis. J Cell Mol Med 2009; 13: 4257-4267.
25. Hilliard A, Hilliard B, Zheng SJ, Sun H, Miwa T, Song W et al. Translational regulation of autoimmune inflammation and lymphoma genesis by programmed cell death 4. J Immunol 2006; 177: 8095-8102.
26. Sheedy FJ, Palsson-McDermott E, Hennessy EJ, Martin C, O'Leary JJ, Ruan Q et al. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol 2010; 11: 141-147.
27. Ruan Q, Wang T, Kameswaran V, Wei Q, Johnson DS, Matschinsky F et al. The microRNA-21-PDCD4 axis prevents type 1 diabetes by blocking pancreatic beta cell death. Proc Natl Acad Sci USA 2011; 108: 12030-12035.
28. Wang X, Zhang L, Wei Z, Zhang X, Gao Q, Ma Y et al. The inhibitory action of PDCD4 in lipopolysaccharide/D-galactosamine-induced acute liver injury. Lab Invest 2013; 93: 291-302.
29. Wang Q, Dong Z, Liu X, Song X, Song Q, Shang Q et al. Programmed cell death-4 deficiency prevents diet-induced obesity, adipose tissue inflammation, and insulin resistance. Diabetes 2013; 62: 4132-4143.
30. Jiang Y, Gao Q, Wang L, Guo C, Zhu F, Wang B et al. Deficiency of programmed cell death 4 results in increased IL-10 expression by macrophages and thereby attenuates atherosclerosis in hyperlipidemic mice. Cell Mol Immunol 2015 (e-pub ahead of print 13 July 2015; doi:10.1038/cmi.2015.47).
31. Song X, Zhang X, Wang X, Zhu F, Guo C, Wang Q et al. Tumor suppressor gene PDCD4 negatively regulates autophagy by inhibiting the expression of autophagy-related gene ATG5. Autophagy 2013; 9: 743-755.
32. Maiuri MC, Grassia G, Platt AM, Carnuccio R, Ialenti A, Maffia P. Macrophage autophagy in atherosclerosis. Mediators Inflamm 2013; 2013: 584715.
33. Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012; 8: 445-544.
34. Platt FM, Boland B, van der Spoel AC. The cell biology of disease: lysosomalstorage disorders: the cellular impact of lysosomal dysfunction. J Cell Biol 2012; 199: 723-734.
35. Emanuel R, Sergin I, Bhattacharya S, Turner JN, Epelman S, Settembre C et al. Induction of lysosomal biogenesis in atherosclerotic macrophages can rescue lipid-induced lysosomal dysfunction and downstream sequelae. Arterioscler Thromb Vasc Biol 2014; 34: 1942-1952.
36. Yu L, McPhee CK, Zheng L, Mardones GA, Rong Y, Peng J et al. Termination of autophagy and reformation of lysosomes regulated by mTOR. Nature 2010; 465: 942-946.
37. Wang N, Lan D, Chen W, Matsuura F, Tall AR. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc Natl Acad Sci USA 2004; 101: 9774-9779.
38. Westerterp M, Bochem A, Yvan-Charvet L, Murphy A, Wang N, Tall A. ATP-binding cassette transporters, atherosclerosis, and inflammation. Circ Res 2014; 114: 157-170.
39. Jia G, Cheng G, Agrawal DK. Autophagy of vascular smooth muscle cells in atherosclerotic lesions. Autophagy 2007; 3: 63-64.
40. Lavandero S, Chiong M, Rothermel B, Hill J. Autophagy in cardiovascular biology. J Clin Invest 2015; 125: 55-64.
41. Nussenzweig S, Verma S, Finkel T. The role of autophagy in vascular biology. Circ Res 2015; 116: 480-488.